Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Tuberculosis and impaired IL-23-dependent IFN-gamma immunity in humans homozygous for a common TYK2 missense variant
Indexado
WoS WOS:000455005400004
Scopus SCOPUS_ID:85058915562
DOI 10.1126/SCIIMMUNOL.AAU8714
Año 2018
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Inherited IL-12R beta 1 and TYK2 deficiencies impair both IL-12- and IL-23 -dependent IFN-gamma immunity and are rare monogenic causes of tuberculosis, each found in less than 1/600,000 individuals. We show that homozygosity for the common TYK2 P1104A allele, which is found in about 1/600 Europeans and between 1/1000 and 1/10,000 individuals in regions other than East Asia, is more frequent in a cohort of patients with tuberculosis from endemic areas than in ethnicity-adjusted controls (P = 8.37 x 10(-8); odds ratio, 89.31; 95% CI, 14.7 to 1725). Moreover, the frequency of P1104A in Europeans has decreased, from about 9% to 4.2%, over the past 4000 years, consistent with purging of this variant by endemic tuberculosis. Surprisingly, we also show that TYK2 P1104A impairs cellular responses to IL-23, but not to IFN-alpha, IL-10, or even IL-12, which, like IL-23, induces IFN-gamma via activation of TYK2 and JAK2. Moreover, TYK2 P1104A is properly docked on cytokine receptors and can be phosphorylated by the proximal JAK, but lacks catalytic activity. Last, we show that the catalytic activity of TYK2 is essential for IL-23, but not IL-12, responses in cells expressing wild-type JAK2. In contrast, the catalytic activity of JAK2 is redundant for both IL-12 and IL-23 responses, because the catalytically inactive P1057A JAK2, which is also docked and phosphorylated, rescues signaling in cells expressing wild-type TYK2. In conclusion, homozygosity for the catalytically inactive P1104A missense variant of TYK2 selectively disrupts the induction of IFN-gamma by IL-23 and is a common monogenic etiology of tuberculosis.

Revista



Revista ISSN
Science Immunology 2470-9468

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Immunology
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Boisson-Dupuis, Stephanie Mujer Rockefeller Univ - Estados Unidos
INSERM - Francia
Paris Descartes Univ - Francia
Rockefeller University - Estados Unidos
l'Institut des Maladies Génétiques Imagine - Francia
Université de Paris - Francia
Université Paris Cité - Francia
2 Ramirez-Alejo, Noe Hombre Rockefeller Univ - Estados Unidos
Rockefeller University - Estados Unidos
3 Li, Zhi - Pasteur Inst - Francia
INSERM - Francia
Institut Pasteur, Paris - Francia
Université Paris Cité - Francia
4 Patin, Etienne Hombre Pasteur Inst - Francia
CNRS - Francia
Institut Pasteur, Paris - Francia
CNRS Centre National de la Recherche Scientifique - Francia
Université Paris Cité - Francia
5 Rao, Geetha Mujer Garvan Inst Med Res - Australia
Garvan Institute of Medical Research - Australia
6 Kerner, Gaspard Hombre INSERM - Francia
Paris Descartes Univ - Francia
l'Institut des Maladies Génétiques Imagine - Francia
Université de Paris - Francia
Université Paris Cité - Francia
7 Lim, Che Kang - Karolinska Univ - Suecia
Singapore Gen Hosp - Singapur
Karolinska University Hospital - Suecia
Singapore General Hospital - Singapur
Karolinska Universitetssjukhuset - Suecia
8 Krementsov, Dimitry N. - Univ Vermont - Estados Unidos
University of Vermont - Estados Unidos
9 Hernandez, Nicholas Hombre Rockefeller Univ - Estados Unidos
Rockefeller University - Estados Unidos
10 Ma, C. S. Mujer Garvan Inst Med Res - Australia
Univ New South Wales - Australia
Garvan Institute of Medical Research - Australia
University of New South Wales (UNSW) Australia - Australia
UNSW Sydney - Australia
11 Zhang, Qian - Rockefeller Univ - Estados Unidos
Sidra Med - Catar
Rockefeller University - Estados Unidos
Sidra Medicine - Catar
12 Markle, Janet G. Mujer Rockefeller Univ - Estados Unidos
Rockefeller University - Estados Unidos
13 Martinez-Barricarte, Ruben Hombre Rockefeller Univ - Estados Unidos
Rockefeller University - Estados Unidos
14 Payne, Kathryn Mujer Garvan Inst Med Res - Australia
Garvan Institute of Medical Research - Australia
15 Fisch, Robert Hombre Rockefeller Univ - Estados Unidos
Rockefeller University - Estados Unidos
16 Deswarte, Caroline Mujer INSERM - Francia
Paris Descartes Univ - Francia
l'Institut des Maladies Génétiques Imagine - Francia
Université de Paris - Francia
Université Paris Cité - Francia
17 Halpern, Joshua Hombre Rockefeller Univ - Estados Unidos
Rockefeller University - Estados Unidos
18 Bouaziz, Matthieu Hombre INSERM - Francia
Paris Descartes Univ - Francia
l'Institut des Maladies Génétiques Imagine - Francia
Université de Paris - Francia
Université Paris Cité - Francia
19 Mulwa, Jeanette Mujer Rockefeller Univ - Estados Unidos
Rockefeller University - Estados Unidos
20 Sivanesan, Durga - UNIV MONTREAL - Canadá
Univ Ottawa - Canadá
University of Montreal - Canadá
University of Ottawa, Canada - Canadá
University of Ottawa - Canadá
21 Lazarov, Tomi Hombre Mem Sloan Kettering Canc Ctr - Estados Unidos
Memorial Sloan-Kettering Cancer Center - Estados Unidos
22 Naves, Rodrigo Hombre Universidad de Chile - Chile
23 GARCIA-SUAREZ, PAULA CONSTANZA Mujer Pontificia Universidad Católica de Chile - Chile
24 Itan, Yuval Hombre Rockefeller Univ - Estados Unidos
Icahn Sch Med Mt Sinai - Estados Unidos
Rockefeller University - Estados Unidos
Icahn School of Medicine at Mount Sinai - Estados Unidos
25 Boisson, Bertrand Hombre Rockefeller Univ - Estados Unidos
INSERM - Francia
Paris Descartes Univ - Francia
Rockefeller University - Estados Unidos
l'Institut des Maladies Génétiques Imagine - Francia
Université de Paris - Francia
Université Paris Cité - Francia
26 Checchi, Alix Mujer INSERM - Francia
Paris Descartes Univ - Francia
l'Institut des Maladies Génétiques Imagine - Francia
Université de Paris - Francia
Université Paris Cité - Francia
27 Jabot-Hanin, Fabienne Mujer INSERM - Francia
Paris Descartes Univ - Francia
l'Institut des Maladies Génétiques Imagine - Francia
Université de Paris - Francia
Université Paris Cité - Francia
28 Cobat, Aurelie Mujer INSERM - Francia
Paris Descartes Univ - Francia
l'Institut des Maladies Génétiques Imagine - Francia
Université de Paris - Francia
Université Paris Cité - Francia
29 Guennoun, Andrea Mujer Sidra Med - Catar
Sidra Medicine - Catar
30 Jackson, Carolyn C. Mujer Rockefeller Univ - Estados Unidos
Mem Sloan Kettering Canc Ctr - Estados Unidos
Rockefeller University - Estados Unidos
Memorial Sloan-Kettering Cancer Center - Estados Unidos
31 Pekcan, Sevgi Mujer Necmettin Erbakan Univ - Turquía
Konya Necmettin Erbakan Üniversitesi - Turquía
Necmettin Erbakan Üniversitesi - Turquía
32 Caliskaner, Zafer Hombre Necmettin Erbakan Univ - Turquía
Konya Necmettin Erbakan Üniversitesi - Turquía
Necmettin Erbakan Üniversitesi - Turquía
33 INOSTROZA-SARMIENTO, JAIME LUIS Hombre Universidad de La Frontera - Chile
34 Costa-Carvalho, B. T. Mujer Univ Fed Sao Paulo - Brasil
Universidade de Sao Paulo - USP - Brasil
Universidade de São Paulo - Brasil
35 Tavares de Albuquerque, Jose Antonio Hombre UNIV SAO PAULO - Brasil
Universidade de Sao Paulo - USP - Brasil
Universidade de São Paulo - Brasil
36 Garcia-Ortiz, Humberto Hombre Natl Inst Genom Med - México
National Institute of Genomic Medicine - México
Instituto Nacional de Medicina Genómica - México
37 Orozco, Lorena Mujer Natl Inst Genom Med - México
National Institute of Genomic Medicine - México
Instituto Nacional de Medicina Genómica - México
38 Ozcelik, Tayfun Hombre Bilkent Univ - Turquía
Bilkent Üniversitesi - Turquía
39 Abid, Ahmed Hombre Mil Hosp Mohammed V - Marruecos
Military Hospital Mohammed V - Marruecos
40 Rhorfi, Ismail Abderahmani Hombre Mil Hosp Mohammed V - Marruecos
UNIV ERLANGEN NURNBERG - Alemania
Military Hospital Mohammed V - Marruecos
Friedrich-Alexander-Universität Erlangen-Nürnberg - Alemania
41 Souhi, Hicham Hombre Mil Hosp Mohammed V - Marruecos
Military Hospital Mohammed V - Marruecos
42 Amrani, Hicham Naji Hombre Mil Hosp Mohammed V - Marruecos
Military Hospital Mohammed V - Marruecos
43 Zegmout, Adil Hombre Mil Hosp Mohammed V - Marruecos
Military Hospital Mohammed V - Marruecos
44 Geissmann, Frederic Hombre Mem Sloan Kettering Canc Ctr - Estados Unidos
Memorial Sloan-Kettering Cancer Center - Estados Unidos
45 Michnick, Stephen W. Hombre UNIV MONTREAL - Canadá
University of Montreal - Canadá
46 Muller-Fleckenstein, Ingrid Mujer UNIV ERLANGEN NURNBERG - Alemania
Friedrich-Alexander-Universität Erlangen-Nürnberg - Alemania
47 Fleckenstein, Bernhard Hombre UNIV ERLANGEN NURNBERG - Alemania
Friedrich-Alexander-Universität Erlangen-Nürnberg - Alemania
48 Puel, Anne Mujer Rockefeller Univ - Estados Unidos
INSERM - Francia
Paris Descartes Univ - Francia
Rockefeller University - Estados Unidos
l'Institut des Maladies Génétiques Imagine - Francia
Université de Paris - Francia
Université Paris Cité - Francia
49 Ciancanelli, Michael J. Hombre Rockefeller Univ - Estados Unidos
Rockefeller University - Estados Unidos
50 Marr, Nico Hombre Sidra Med - Catar
Sidra Medicine - Catar
51 Abolhassani, Hassan Hombre Karolinska Univ - Suecia
Univ Tehran Med Sci - Iran
Karolinska University Hospital - Suecia
Research Center for Immunodeficiencies - Iran
52 Balcells-M, Maria Elvira Mujer Pontificia Universidad Católica de Chile - Chile
53 Condino-Neto, A. Hombre UNIV SAO PAULO - Brasil
Universidade de Sao Paulo - USP - Brasil
Universidade de São Paulo - Brasil
54 Strickler, Alexis Hombre San Sebastian Univ - Chile
Universidad San Sebastián - Chile
55 ABARCA-VILLASECA, KATIA Mujer Pontificia Universidad Católica de Chile - Chile
56 Teuscher, Cory Hombre Univ Vermont - Estados Unidos
University of Vermont College of Medicine - Estados Unidos
University of Vermont - Estados Unidos
University of Vermont Larner College of Medicine - Estados Unidos
57 Ochs, Hans D. Hombre UNIV WASHINGTON - Estados Unidos
University of Washington School of Medicine - Estados Unidos
University of Washington - Estados Unidos
58 Reisli, Ismail Hombre Necmettin Erbakan Univ - Turquía
Konya Necmettin Erbakan Üniversitesi - Turquía
Necmettin Erbakan Üniversitesi - Turquía
59 Sayar, Esra H. Mujer Necmettin Erbakan Univ - Turquía
Konya Necmettin Erbakan Üniversitesi - Turquía
Necmettin Erbakan Üniversitesi - Turquía
60 El-Baghdadi, Jamila Mujer Mil Hosp Mohamed V - Marruecos
Military Hospital Mohammed V - Marruecos
Mil Hosp Mohammed V - Marruecos
61 Bustamante, Jacinta Mujer Rockefeller Univ - Estados Unidos
INSERM - Francia
Paris Descartes Univ - Francia
Necker Hosp Sick Children - Francia
Rockefeller University - Estados Unidos
l'Institut des Maladies Génétiques Imagine - Francia
Université de Paris - Francia
Hôpital Necker Enfants Malades - Francia
Université Paris Cité - Francia
62 Hammarstrom, Lennart Hombre Karolinska Univ - Suecia
Singapore Gen Hosp - Singapur
Beijing Genom Inst BGI Shenzhen - China
Karolinska University Hospital - Suecia
Singapore General Hospital - Singapur
BGI-Shenzhen - China
Karolinska Universitetssjukhuset - Suecia
63 Tangye, Stuart G. Hombre Garvan Inst Med Res - Australia
Univ New South Wales - Australia
Garvan Institute of Medical Research - Australia
University of New South Wales (UNSW) Australia - Australia
UNSW Sydney - Australia
64 Pellegrini, Sandra Mujer Pasteur Inst - Francia
INSERM - Francia
Institut Pasteur, Paris - Francia
Université Paris Cité - Francia
65 Quintana-Murci, Lluis Hombre Pasteur Inst - Francia
CNRS - Francia
Institut Pasteur, Paris - Francia
CNRS Centre National de la Recherche Scientifique - Francia
Université Paris Cité - Francia
66 Abel, Laurent Hombre Rockefeller Univ - Estados Unidos
INSERM - Francia
Paris Descartes Univ - Francia
Rockefeller University - Estados Unidos
l'Institut des Maladies Génétiques Imagine - Francia
Université de Paris - Francia
Université Paris Cité - Francia
67 Casanova, Jean Laurent Hombre Rockefeller Univ - Estados Unidos
INSERM - Francia
Paris Descartes Univ - Francia
Necker Hosp Sick Children - Francia
Howard Hughes Med Inst - Estados Unidos
Rockefeller University - Estados Unidos
l'Institut des Maladies Génétiques Imagine - Francia
Université de Paris - Francia
Hôpital Necker Enfants Malades - Francia
Howard Hughes Medical Institute - Estados Unidos
Université Paris Cité - Francia

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Origen de Citas Identificadas



Muestra la distribución de países cuyos autores citan a la publicación consultada.

Citas identificadas: Las citas provienen de documentos incluidos en la base de datos de DATACIENCIA

Citas Identificadas: 0.65 %
Citas No-identificadas: 99.35 %

Muestra la distribución de instituciones nacionales o extranjeras cuyos autores citan a la publicación consultada.

Citas identificadas: Las citas provienen de documentos incluidos en la base de datos de DATACIENCIA

Citas Identificadas: 0.65 %
Citas No-identificadas: 99.35 %

Financiamiento



Fuente
Consejo Nacional de Ciencia y Tecnología (CONACYT)
Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT)
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
National Institutes of Health
CNRS
National Heart, Lung, and Blood Institute
Seventh Framework Programme
Agence Nationale de la Recherche
National Institute of Allergy and Infectious Diseases (NIAID)
NIAID
National Institute of Allergy and Infectious Diseases
European Research Council (ERC)
National Human Genome Research Institute
National Health and Medical Research Council of Australia
St. Giles Foundation
Rockefeller University
Jeffrey Modell Foundation
National Center for Research Resources
Office of Health and Medical Research of the Government of New South Wales (Australia)
SCOR Corporate Foundation for Science
National Center for Advancing Sciences (NCATS), NIH
TBPATHGEN project
Damon Runyon Cancer Research Foundation
Charles H. Revson Senior Fellowship in Biomedical Sciences
Fundacao de Amparo a Pesquisa do Estado e de Sao Paulo (Fapesp)
French National Agency for Research (ANR)
Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence
Stony Wold-Herbert Fund
GENMSMD project
Fondation de la Recherche Medicale
Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
The Laboratory of Human Genetics of Infectious Diseases was supported, in part, by grants from the French National Agency for Research (ANR) under the "Investissement d'avenir" program (grant no. ANR-10-IAHU-01), the TBPATHGEN project (grant no. ANR-14-CE14-0007-01), the GENMSMD project (grant no. ANR-16-CE17-0005-01), the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (grant no. ANR-10-LABX-62-IBEID), the European Research Council (ERC; grant no. ERC-2010-AdG-268777), the SCOR Corporate Foundation for Science, the St. Giles Foundation, the National Center for Research Resources and the National Center for Advancing Sciences (NCATS), NIH (grant no. UL1TR001866), the National Institute of Allergy and Infectious Diseases (NIAID) (grant nos. 5R01AI089970, 5R37AI095983, 5U01AI088685, and 5U19AI111143), and The Rockefeller University. Work at the Cytokine Signaling Unit was supported, in part, by a grant from Fondation de la Recherche Medicale to S. Pellegrini (grant no. DEQ20170336741). J.B. was supported by Support of Clinical Research (grant no. SRC2017). C.S.M. and S.G.T. were supported by fellowships and grants from the National Health and Medical Research Council of Australia and the Office of Health and Medical Research of the Government of New South Wales (Australia). M.E.B. was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT; grant no. 1171570) A.C.-N. was supported by Fundacao de Amparo a Pesquisa do Estado e de Sao Paulo (Fapesp) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). N.R.-A. was supported by fellowships from Consejo Nacional de Ciencia y Tecnologia (CONACYT; grant no. 264011) and the Stony Wold-Herbert Fund. Z.L. was supported by the CNRS. J. Markle was supported by the Charles H. Revson Senior Fellowship in Biomedical Sciences and NIAID grant K99AI27932. C.C.J. was the Damon Runyon-Richard Lumsden Foundation Physician Scientist supported by the Damon Runyon Cancer Research Foundation (PST-03-15). H.D.O. was supported by the Jeffrey Modell Foundation. N.H. was supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH under award no. T32GM007739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program. The content of this study is the sole responsibility of the authors and does not necessarily represent the official views of the NIH. The Yale Center for Mendelian Genomics (UM1HG006504) is funded by the National Human Genome Research Institute. Funds were also provided by the National Heart, Lung, and Blood Institute. The GSP Coordinating Center (U24 HG008956) contributed to cross-program scientific initiatives and provided logistical and general study coordination.
We would like to thank the patients, their relatives, and their physicians. We also thank Y. Nemirovskaya, T. Kochetkov, D. Papandrea, S. O. Lugo Reyes, L. Blancas Galicia, M. Orlova, E. Schurr, A. Bousfiha, L. Lorenzo-Diaz, C. Desvallees, C. Patissier, C. Carvajal, N. Scioscia, F. Zegna-Ratá, and C. Tiznado. The Laboratory of Human Genetics of Infectious Diseases was supported, in part, by grants from the French National Agency for Research (ANR) under the “Investissement d’avenir” program (grant no. ANR-10-IAHU-01), the TBPATHGEN project (grant no. ANR-14-CE14-0007-01), the GENMSMD project (grant no. ANR-16-CE17-0005-01), the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (grant no. ANR-10-LABX-62-IBEID), the European Research Council (ERC; grant no. ERC-2010-AdG-268777), the SCOR Corporate Foundation for Science, the St. Giles Foundation, the National Center for Research Resources and the National Center for Advancing Sciences (NCATS), NIH (grant no. UL1TR001866), the National Institute of Allergy and Infectious Diseases (NIAID) (grant nos. 5R01AI089970, 5R37AI095983, 5U01AI088685, and 5U19AI111143), and The Rockefeller University. Work at the Cytokine Signaling Unit was supported, in part, by a grant from Fondation de la Recherche Médicale to S. Pellegrini (grant no. DEQ20170336741). J.B. was supported by Support of Clinical Research (grant no. SRC2017). C.S.M. and S.G.T. were supported by fellowships and grants from the National Health and Medical Research Council of Australia and the Office of Health and Medical Research of the Government of New South Wales (Australia). M.E.B. was supported by Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT; grant no. 1171570) A.C.-N. was supported by Fundação de Amparo a Pesquisa do Estado e de São Paulo (Fapesp) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). N.R.-A. was supported by fellowships from Consejo Nacional de Ciencia y Tecnología (CONACYT; grant no. 264011) and the Stony Wold-Herbert Fund. Z.L. was supported by the CNRS. J. Markle was supported by the Charles H. Revson Senior Fellowship in Biomedical Sciences and NIAID grant K99AI27932. C.C.J. was the Damon Runyon-Richard Lumsden Foundation Physician Scientist supported by the Damon Runyon Cancer Research Foundation (PST-03-15). H.D.O. was supported by the Jeffrey Modell Foundation. N.H. was supported by a Medical Scientist Training Program grant from the National Institute of General Medical Sciences of the NIH under award no. T32GM007739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program. The content of this study is the sole responsibility of the authors and does not necessarily represent the official views of the NIH. The Yale Center for Mendelian Genomics (UM1HG006504) is funded by the National Human Genome Research Institute. Funds were also provided by the National Heart, Lung, and Blood Institute. The GSP Coordinating Center (U24 HG008956) contributed to cross-program scientific initiatives and provided logistical and general study coordination.

Muestra la fuente de financiamiento declarada en la publicación.